Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia 42Breast Neoplasms 32Carcinoma, Non-Small-Cell Lung 22Leukemia, Myeloid, Acute 21Lung Neoplasms 19Congenital Abnormalities 17Kidney Neoplasms 16Rectal Neoplasms 15Lymphoma 15Head and Neck Neoplasms 15Colorectal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Melanoma 14Colonic Neoplasms 14Sarcoma 13Lymphoma, Follicular 11Carcinoma, Renal Cell 11Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Prostatic Neoplasms 9Leukemia, Myelomonocytic, Acute 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Central Nervous System Neoplasms 9Multiple Myeloma 8Leukemia, Lymphocytic, Chronic, B-Cell 7Gliosarcoma 7Glioblastoma 7Esophageal Neoplasms 7

Interventions

Paclitaxel 8Oxaliplatin 6Carboplatin 5Vincristine 4Radiotherapy 4Mental Status and Dementia Tests 4Leucovorin 4Amifostine 4Taxes 3Sodium Chloride 3Procarbazine 3Methotrexate 3Magnetic Resonance Spectroscopy 3Fluorouracil 3Cytarabine 3Cyclophosphamide 3Cisplatin 3xaliproden 2glucarpidase 2Surveys and Questionnaires 2Rituximab 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Prednisolone 2Magnesium Sulfate 2Folfox protocol 2Duloxetine Hydrochloride 2Doxorubicin 2Dexamethasone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Gene Expression Profiling × Clear all
NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

National Cancer Institute (NCI)

Phase 2 Unknown
206 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡